tRNA Charging Analysis in Cancer – Melanoma Therapy Resistance
ArticleValine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma Published inNature Cell Biology AbstractThis study identified valine aminoacyl-tRNA synthetase (VARS), a key enzyme in the tRNA charging machinery, as a critical regulator of resistance to MAPK-targeted therapy in melanoma. MAPK inhibitor–resistant melanoma cells exhibited increased expression and activity of VARS, accompanied by enrichment of valine-containing proteins […]
tRNA Charging Analysis in Cancer – Melanoma Therapy Resistance Read More »